BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34994382)

  • 1. Loss of p19Arf promotes fibroblast survival during leucine deprivation.
    Roby KC; Lieberman A; Kim BJ; Rodríguez NZ; Posimo JM; Tsang T; Verginadis II; Puré E; Brady DC; Koumenis C; Ryeom S
    Biol Open; 2022 Feb; 11(2):. PubMed ID: 34994382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of Rho family GTPases in p19Arf- and p53-mediated proliferation of primary mouse embryonic fibroblasts.
    Guo F; Zheng Y
    Mol Cell Biol; 2004 Feb; 24(3):1426-38. PubMed ID: 14729984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal polyubiquitination and degradation of the Arf tumor suppressor.
    Kuo ML; den Besten W; Bertwistle D; Roussel MF; Sherr CJ
    Genes Dev; 2004 Aug; 18(15):1862-74. PubMed ID: 15289458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis.
    Rogoff HA; Pickering MT; Debatis ME; Jones S; Kowalik TF
    Mol Cell Biol; 2002 Aug; 22(15):5308-18. PubMed ID: 12101227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p14ARF is a component of the p53 response following ionizing irradiation of normal human fibroblasts.
    Khan S; Guevara C; Fujii G; Parry D
    Oncogene; 2004 Aug; 23(36):6040-6. PubMed ID: 15195142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p19ARF prevents G1 cyclin-dependent kinase activation by interacting with MDM2 and activating p53 in mouse fibroblasts.
    Kurokawa K; Tanaka T; Kato J
    Oncogene; 1999 Apr; 18(17):2718-27. PubMed ID: 10348346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53-independent apoptosis is induced by the p19ARF tumor suppressor.
    Tsuji K; Mizumoto K; Sudo H; Kouyama K; Ogata E; Matsuoka M
    Biochem Biophys Res Commun; 2002 Jul; 295(3):621-9. PubMed ID: 12099684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple domains of the mouse p19ARF tumor suppressor are involved in p53-independent apoptosis.
    Matsuoka M; Kurita M; Sudo H; Mizumoto K; Nishimoto I; Ogata E
    Biochem Biophys Res Commun; 2003 Feb; 301(4):1000-10. PubMed ID: 12589812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p19ARF-induced p53-independent apoptosis largely occurs through BAX.
    Suzuki H; Kurita M; Mizumoto K; Nishimoto I; Ogata E; Matsuoka M
    Biochem Biophys Res Commun; 2003 Dec; 312(4):1273-7. PubMed ID: 14652011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
    Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
    Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CARF is a novel protein that cooperates with mouse p19ARF (human p14ARF) in activating p53.
    Hasan MK; Yaguchi T; Sugihara T; Kumar PK; Taira K; Reddel RR; Kaul SC; Wadhwa R
    J Biol Chem; 2002 Oct; 277(40):37765-70. PubMed ID: 12154087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.
    Kamijo T; Zindy F; Roussel MF; Quelle DE; Downing JR; Ashmun RA; Grosveld G; Sherr CJ
    Cell; 1997 Nov; 91(5):649-59. PubMed ID: 9393858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of endogenous p53 by combined p19Arf gene transfer and nutlin-3 drug treatment modalities in the murine cell lines B16 and C6.
    Merkel CA; da Silva Soares RB; de Carvalho AC; Zanatta DB; Bajgelman MC; Fratini P; Costanzi-Strauss E; Strauss BE
    BMC Cancer; 2010 Jun; 10():316. PubMed ID: 20569441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest.
    Rowland BD; Denissov SG; Douma S; Stunnenberg HG; Bernards R; Peeper DS
    Cancer Cell; 2002 Jul; 2(1):55-65. PubMed ID: 12150825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular scaffold kinase suppressor of Ras 1 is a modifier of RasV12-induced and replicative senescence.
    Kortum RL; Johnson HJ; Costanzo DL; Volle DJ; Razidlo GL; Fusello AM; Shaw AS; Lewis RE
    Mol Cell Biol; 2006 Mar; 26(6):2202-14. PubMed ID: 16507997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p16INK4A and p19ARF act in overlapping pathways in cellular immortalization.
    Carnero A; Hudson JD; Price CM; Beach DH
    Nat Cell Biol; 2000 Mar; 2(3):148-55. PubMed ID: 10707085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p19Arf-p53 tumor suppressor pathway regulates cell motility by suppression of phosphoinositide 3-kinase and Rac1 GTPase activities.
    Guo F; Gao Y; Wang L; Zheng Y
    J Biol Chem; 2003 Apr; 278(16):14414-9. PubMed ID: 12578823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis.
    Moore L; Venkatachalam S; Vogel H; Watt JC; Wu CL; Steinman H; Jones SN; Donehower LA
    Oncogene; 2003 Oct; 22(49):7831-7. PubMed ID: 14586409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
    Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleophosmin is required for DNA integrity and p19Arf protein stability.
    Colombo E; Bonetti P; Lazzerini Denchi E; Martinelli P; Zamponi R; Marine JC; Helin K; Falini B; Pelicci PG
    Mol Cell Biol; 2005 Oct; 25(20):8874-86. PubMed ID: 16199867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.